Prevalence and Characteristics of Painful Diabetic Neuropathy in a Large Community-Based Diabetic Population in the U.K.
Open accessThe DOI matches its Crossref record; 19 of the 19 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To assess, in the general diabetic population, 1) the prevalence of painful neuropathic symptoms; 2) the relationship between symptoms and clinical severity of neuropathy; and 3) the role of diabetes type, sex, and ethnicity in painful neuropathy. RESEARCH DESIGN AND METHODS: Observational study of a large cohort of diabetic patients receiving community-based health care in northwest England (n = 15,692). Painful diabetic neuropathy (PDN) was assessed using neuropathy symptom score (NSS) and neuropathy disability score (NDS). RESULTS: Prevalence of painful symptoms (NSS ≥5) and PDN (NSS ≥5 and NDS ≥3) was 34 and 21%, respectively. Painful symptoms occurred in 26% of patients without neuropathy (NDS ≤2) and 60% of patients with severe neuropathy (NDS >8). Adjusted risk of painful neuropathic symptoms in type 2 diabetes was double that of type 1 diabetes (odds ratio [OR] = 2.1 [95% CI 1.7–2.4], P < 0.001) and not affected by severity of neuropathy, insulin use, foot deformities, smoking, or alcohol. Women had 50% increased adjusted risk of painful symptoms compared with men (OR = 1.5 [1.4–1.6], P < 0.0001). Despite less neuropathy in South Asians (14%) than Europeans (22%) and African Caribbeans (21%) (P < 0.0001), painful symptoms were greater in South Asians (38 vs. 34 vs. 32%, P < 0.0001). South Asians without neuropathy maintained a 50% increased risk of painful neuropathy symptoms compared with other ethnic groups (P < 0.0001). CONCLUSIONS: One-third of all community-based diabetic patients have painful neuropathy symptoms, regardless of their neuropathic deficit. PDN was more prevalent in patients with type 2 diabetes, women, and people of South Asian origin. This highlights a significant morbidity due to painful neuropathy and identifies key groups who warrant screening for PDN.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Diabetic peripheral polyneuropathy (also known as diabetic neuropathy) affects 50% of patients with diabetes [3–5]”
From A Consideration of the Psychological Aspects to Managing Patients with Painful Diabetic Neuropathy: An Insight into Pain Management Services at a Tertiary Centre in the UK (2021) · cites this paper as [4]
Experimental — accuracy not yet measuredIn the citing paper
“with previous studies suggesting that it affects 21% of patients with neuropathy (23)”
From Development of a Core Outcome Set for Studies Assessing Interventions for Diabetes-Related Foot Ulceration (2024) · cites this paper as [23]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The global burden of diabetic foot disease
Boulton, A. J., Vileikyte, L., Ragnarson-Tennvall, G., & Apelqvist, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67698-2 · Cited by 2,566
Self-citationYoung, M. J., Boulton, A. J. M., Macleod, A. F., Williams, D. R. R., & Sonksen, P. H. (1993) · Diabetologia · doi:10.1007/bf00400697 · Cited by 1,502
Self-citationAbbott, C. A., Carrington, A. L., Ashe, H., Bath, S., Every, L. C., Griffiths, J., Hann, A. W., Hussein, A., Jackson, N., Johnson, K. E., et al. (2002) · Diabetic Medicine · doi:10.1046/j.1464-5491.2002.00698.x · Cited by 1,056
Self-citationThe Prevalence, Severity, and Impact of Painful Diabetic Peripheral Neuropathy in Type 2 Diabetes
Davies, M., Brophy, S., Williams, R., & Taylor, A. (2006) · Diabetes Care · doi:10.2337/dc05-2228 · Cited by 746
Tesfaye, S., Stevens, L. K., Stephenson, J. M., Fuller, J. H., Plater, M., Ionescu-Tirgoviste, C., Nuber, A., Pozza, G., & Ward, J. D. (1996) · Diabetologia · doi:10.1007/s001250050586 · Cited by 695
Bril, V., England, J., Franklin, G. M., Backonja, M., Cohen, J., Del Toro, D., Feldman, E., Iverson, D. J., Perkins, B., Russell, J. W., et al. (2011) · Neurology · doi:10.1212/wnl.0b013e3182166ebe · Cited by 634
Daousi, C., MacFarlane, I. A., Woodward, A., Nurmikko, T. J., Bundred, P. E., & Benbow, S. J. (2004) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01271.x · Cited by 454
Foot complications in Type 2 diabetes: an Australian population‐based study
Tapp, R. J., Shaw, J. E., De Courten, M. P., Dunstan, D. W., Welborn, T. A., & Zimmet, P. Z. (2003) · Diabetic Medicine · doi:10.1046/j.1464-5491.2003.00881.x · Cited by 193
Cabezas-Cerrato, J. (1998) · Diabetologia · doi:10.1007/s001250051063 · Cited by 192
Abbott, C. A., Garrow, A. P., Carrington, A. L., Morris, J., Van Ross, E. R., & Boulton, A. J. (2005) · Diabetes Care · doi:10.2337/diacare.28.8.1869 · Cited by 171
Self-citation
Cited by
Items 601–700 of 870
Dysphagia as a Manifestation of Endocrine and Metabolic Disorders
Maria, C. S., & O'Dell, K. D. (2024) · Otolaryngologic Clinics of North America · doi:10.1016/j.otc.2024.02.024 · Cited by 4
Wang, R., Xuan, D., Xuan, J., Dai, D., Ye, X., & Hu, X. (2025) · ClinicoEconomics and Outcomes Research · doi:10.2147/ceor.s501243 · Cited by 4
Diabetic peripheral neuropathy: Role of nitric oxide
Bahadoran, Z., & Ghasemi, A. (2025) · Nitric Oxide · doi:10.1016/j.niox.2025.10.002 · Cited by 4
Mondal, A., Banerjee, S. S., Naskar, S., Bose, C., Saha, C., Pramanik, S., Mukherjee, B., Jati, P., Sahana, P. K., Malik, R. A., et al. (2025) · European Journal of Neurology · doi:10.1111/ene.70449 · Cited by 3
Self-citationMing, Z., Liu, Y., Jia, S., Su, Y., Yan, W., & Lin, J. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1750051 · Cited by 5
“Among diabetic patients, 20% to 30% are likely to progress to Painful Diabetic Neuropathy (PDN) (3), Common clinical manifestations include intense foot pain, burning sensations, or needle-like pain.”
Kim, Y. J., Lee, J. M., Lee, C. W., Chung, C. H., Lee, J. H., Ko, S., Cho, D. H., Lee, J. H., Cho, H., Kim, S. S., et al. (2022) · Journal of Diabetes Investigation · doi:10.1111/jdi.13880 · Cited by 4
Khandelwal, D., Mathur, V., Sharma, D., & Vyas, A. (2022) · Neurology Asia · doi:10.54029/2022ayc · Cited by 4
Safety and efficacy of duloxetine versus gabapentin in painful diabetic polyneuropathy
Byndoor, Y., & Sagar, T. V. (2023) · IP International Journal of Comprehensive and Advanced Pharmacology · doi:10.18231/j.ijcaap.2022.042 · Cited by 5
Gierthmühlen, J., Attal, N., Baskozos, G., Bennedsgaard, K., Bennett, D., Bouhassira, D., Crombez, G., Finnerup, N. B., Granovsky, Y., Jensen, T. S., et al. (2024) · Pain · doi:10.1097/j.pain.0000000000003310 · Cited by 14
Top 10 Clinical Pearls in Paraproteinemic Neuropathies
Becker, B., & Stino, A. M. (2024) · Seminars in Neurology · doi:10.1055/s-0044-1791769 · Cited by 3
Neural networks involved in painful diabetic neuropathy: A systematic review
Axelsen, J. L., Kirk, U., Andersen, S. B., Schmidt, J. J., Gaarde, M. B., Franck, C. L., van Duinkerken, E., & Pouwer, F. (2025) · Scandinavian Journal of Pain · doi:10.1515/sjpain-2024-0069 · Cited by 4
Li, B. (2025) · World Journal of Diabetes · doi:10.4239/wjd.v16.i8.110285 · Cited by 4
Diabetes and foot problems: The role of the practice nurse
Nazarko, L. (2019) · Practice Nursing · doi:10.12968/pnur.2019.30.1.9 · Cited by 3
Detection of diabetic polyneuropathy in a family medicine clinic by using monofilament
Lakić, B., Petrović, V., Račić, M., & Stanetić, K. (2020) · Vojnosanitetski pregled · doi:10.2298/vsp200226053l · Cited by 3
“from North West England showed that type 2 DM patients, women, and the South Asian population have higher incidence of DNP (5).”
BackgroundFateh, H. R., & Madani, S. P. (2021) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-020-00710-1 · Cited by 4
“presentation and a high prevalence of asymptomatic patients [8, 16, 17].”
BackgroundSchlereth, T., Morellini, N. M., Lismont, N. C. A. M., Lemper, C., Birklein, F., & Drummond, P. D. (2021) · Autonomic Neuroscience · doi:10.1016/j.autneu.2021.102814 · Cited by 3
Clinical Profile of Patients with Diabetes Mellitus in Gusau, Northwestern, Nigeria
Sada, K. B., Sabir, A. A., Sakajiki, A. M., Umar, M. T., Abdullahi, U., & Sikiru, Y. A. (2021) · Annals of African Medicine · doi:10.4103/aam.aam_16_20 · Cited by 7
Li, M., Yao, L., Huang, H., Zhang, L., Zheng, H., Wang, G., Zhong, Z., Ma, S., Yu, S., & Wang, H. (2021) · Trials · doi:10.1186/s13063-021-05773-w · Cited by 3
Li, A. P. Z., & Whyte, M. (2021) · EMJ Diabetes · doi:10.33590/emjdiabet/21-00194 · Cited by 6
Bricio‐Barrios, J. A., Ríos-Bracamontes, E. F., Ríos‐Silva, M., et al. (2021) · World Journal of Clinical Cases · doi:10.12998/wjcc.v10.i1.177 · Cited by 3
Amorizzo, E., SANCTIS, F. D., & Baldeschi, G. C. (2023) · Anesthesiology and Pain Medicine · doi:10.5812/aapm-134901 · Cited by 3
“Diabetic polyneuropathy (DPN) occurs in 20% - 30% of patients (1), and it is defined as a distal, symmetric polyneuropathy with sensory symptoms, including pain, paresthesias, burning, allodynia, and hyperalgesia (2); also, it is described as motor and autonomic neuropathy.”
BackgroundApproach to Painful Diabetic Peripheral Neuropathy
Lumpatki, S. B., Kavitha, K. V., Manohar, M., & Unnikrishnan, A. G. (2022) · Chronicle of Diabetes Research and Practice · doi:10.4103/cdrp.cdrp_4_22 · Cited by 3
Das, M., Chakraborty, M., Das, P., Santra, S., Mukherjee, A., Das, S., Bànyai, K., Roy, S., Choudhury, L., Gupta, R., et al. (2024) · Biocatalysis and Agricultural Biotechnology · doi:10.1016/j.bcab.2024.103176 · Cited by 5
The analgesic effects of insulin and its disorders in streptozotocin‐induced short‐term diabetes
Basatinya, A. M., Sajedianfard, J., Nazıfı, S., & Hosseinzadeh, S. (2024) · Physiological Reports · doi:10.14814/phy2.16009 · Cited by 2
Ahmed, A. M., Al-Nuaimi, S., Mustafa, A., Zeidan, A., Agouni, A., & Djouhri, L. (2024) · Journal of Pain Research · doi:10.2147/jpr.s467535 · Cited by 4
Epigenetic modifications associated to diabetic peripheral neuropathic pain (Review)
Gao, T., Luo, J., Fan, J., Gong, G., & Yang, H. (2024) · Molecular Medicine Reports · doi:10.3892/mmr.2024.13394 · Cited by 3
“Diabetic peripheral neuro‑ pathic pain (DPNP) is a frequent and devastating complication of DM, affecting 25‑30% of patients with DM (2,3).”
Chronic Inflammatory Demyelinating Polyneuropathy in Diabetes Patients
Abraham, A., Alabdali, M. M., Qrimli, M., Barnett, C., Katzberg, H. D., Perkins, B. A., & Bril, V. (2015) · touchREVIEWS in Neurology · doi:10.17925/usn.2015.11.01.47 · Cited by 3
Are Vitamin D and B Deficiency Relevant To the Pathogenesis and Treatment of Diabetic Neuropathy?
Alam, U., Asghar, O., & Malik, R. A. (2012) · Future Neurology · doi:10.2217/fnl.12.24 · Cited by 3
Self-citationElkhamisy, E. T., Khalel, M. S., Elbioumy, A. A., & El-Nahas, M. (2017) · Clinical Diabetology · doi:10.5603/dk.2017.0027 · Cited by 3
Main metabolic and toxic polyneuropathies in clinical practice
Пизова, Н. В. (2021) · Meditsinskiy sovet = Medical Council · doi:10.21518/2079-701x-2021-19-134-146 · Cited by 3
Pang, E. K., & Rudd‐Barnard, G. (2020) · Elsevier eBooks · doi:10.1016/b978-0-323-72216-2.00005-3 · Cited by 3
Bhandari, R., Badyal, P., Khanna, G., & Kuhad, A. (2022) · Springer eBooks · doi:10.1007/978-981-16-9232-1_20 · Cited by 4
Corneal confocal microscopy in patients with distal symmetric polyneuropathy compared to controls
Pupe, C., Dieckmann, G., Dornas, R. M., & Nascimento, O. J. M. (2022) · Arquivos de Neuro-Psiquiatria · doi:10.1055/s-0042-1755231 · Cited by 3
Small fiber neuropathy and sodium channels : a paradigm shift
Hoeijmakers, J. G. J. (2014) · Research Publications (Maastricht University) · doi:10.26481/dis.20140214jh · Cited by 3
Wlazlo, N. (2014) · Research Publications (Maastricht University) · doi:10.26481/dis.20140514nw · Cited by 3
Inceu, G., Rusu, A., Gavan, N. A., & Bala, C. G. (2024) · Journal of Clinical Medicine · doi:10.3390/jcm13226858 · Cited by 2
“A large cohort study enrolling over 15,000 patients with diabetes from England found that women had a 50% higher risk of painful diabetic neuropathy compared to men, independent of age and diabetes duration [26].”
Stemper, B., Löwen, S., Fritsch, A., Hoffmann, A., & Sarkar, A. (2025) · Pain · doi:10.1097/j.pain.0000000000003642 · Cited by 2
Codony, S., Jora, B., Santos-Caballero, M., Qiu, Q., Calvó‐Tusell, C., Escriche, C., Turcu, A. L., Prischi, F., Bartra, C., Val, C., et al. (2025) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2025.2574990 · Cited by 2
Shi, Y., Chen, Y., & Zhao, H. (2026) · Frontiers in Endocrinology · doi:10.3389/fendo.2026.1750441 · Cited by 3
Diabetic neuropathy and fracture risk – a nation-wide case/control study
Graversen, J. L., Kvist, A. V., Rasmussen, N. H., Vestergaard, P., & Røikjer, J. (2026) · Bone · doi:10.1016/j.bone.2026.117860 · Cited by 2
Dubinina, I. I., Берстнева, С. В., Баранов, В. В., et al. (2016) · Diabetes Mellitus · doi:10.14341/dm7637 · Cited by 2
Wojtera, M., & Sobów, T. (2018) · Psychiatria i Psychologia Kliniczna · doi:10.15557/pipk.2018.0010 · Cited by 2
Alam, U., SLOAN, G. P., & Tesfaye, S. H. (2020) · Drugs · doi:10.1007/s40265-020-01351-7 · Cited by 2
Aldossari, K. K., Al-Ghamdi, S. H., Alzahrani, J. M., Turki, M. S. A., Almuhareb, M., Alanazi, Z. A., Alshahrani, Z. M., & Wong, J. (2021) · Current Diabetes Reviews · doi:10.2174/1573399817666210211095610 · Cited by 3
Diabetic Peripheral Neuropathy
Abraham, M. M., Sudan, S. H. H., & Venugopal, P. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.100859 · Cited by 4
Characteristics and Treatment of Painful Diabetic Neuropathy
Gylfadottir, S. S., & Finnerup, N. B. (2023) · Contemporary diabetes · doi:10.1007/978-3-031-15613-7_25 · Cited by 2
Neurologic Complications of Endocrine Disorders
Reda, H. M. (2023) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/con.0000000000001262 · Cited by 3
DOĞAN, A. G., & Uzeli, Ü. Ş. (2023) · Cureus · doi:10.7759/cureus.41490 · Cited by 6
“DN causes an additional burden to the healthcare system due to complications such as foot ulceration, Charcot neuroarthropathy, and lower extremity amputation [3].”
BackgroundLin, H.-S., Yang, C., Yin, T., Sung, P., Chiang, J. Y., Shao, P., Chen, Y.-L., Huang, C., Yip, H., & Chen, K. (2023) · PubMed Central · Cited by 2
Lin, Y. S., Chan, N., Xiao, P.-Y., & Lai, C. J. (2024) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00297.2023 · Cited by 4
The irreversible, towards fatalic neuropathy: from the genesis of diabetes
Pal, B., Ghosh, R., Sarkar, R. D., & Roy, G. S. (2024) · Acta Diabetologica · doi:10.1007/s00592-024-02429-4 · Cited by 4
“In a study from England of 15,692 indi - viduals with diabetes, the prevalence of sensory neuropathy (SN), described by the impairment of pinprick, temperature sensation, and vibration were 49%, but the prevalence of neuropathic algesia indication was 34% [ 14].”
SIRT1 Attenuates Neuropathic Pain via CDK5-Kalirin-7 Signaling Pathway in Type 2 Diabetic Rats
Xie, C., Cao, Y., Shen, Y., Wu, S., Wang, J., Ye, X., Wei, N., Cao, H., & Li, J. (2025) · Molecular Neurobiology · doi:10.1007/s12035-025-04843-3 · Cited by 2
“Research indicates approximately half of type 2 diabetes (T2D) patients experience diabetic neuropathic pain (DNP), which represents a prevalent long-term consequence of diabetes mellitus [1, 2].”
A prospective study of small fiber neuropathy in AL amyloidosis
Bountziouka, C., Fotiou, D., Theodorakakou, F., Papanikolaou, A., Gavriatopoulou, M., Terpos, E., Dimopoulos, M. A., Kastritis, E., & Kokotis, P. (2025) · Amyloid · doi:10.1080/13506129.2025.2500364 · Cited by 3
Herman, W. H., Ciarleglio, A., Callaghan, B. C., Edelstein, S. L., Goldberg, R. B., White, N. H., Albers, J. W., Bray, G. A., Gadde, K. M., Culbert, I. W., et al. (2025) · Diabetes Care · doi:10.2337/dc25-0596 · Cited by 5
Intravenous Streptozotocin Induces Variants in Painful Diabetic Peripheral Neuropathy in Female Mice
Hagenimana, M. A., Green, A. R., Tierney, J. A., Lenert, M. E., & Burton, M. D. (2025) · Journal of Pain Research · doi:10.2147/jpr.s523693 · Cited by 2
Song, J., Cong, S., & Qiao2, Y. (2021) · Tropical Journal of Pharmaceutical Research · doi:10.4314/tjpr.v20i1.10 · Cited by 2
“Trop J Pharm Res, January 2021; 20(1): 62 an increased economic burden for diabetes care [1,2].”
BackgroundLechleitner, M., Abrahamian, H., & Francesconi, M. (2012) · Wiener klinische Wochenschrift · doi:10.1007/s00508-012-0267-1 · Cited by 2
Jensen, T. S. (2013) · Scandinavian Journal of Pain · doi:10.1016/j.sjpain.2013.04.004 · Cited by 2
Efficacy of Actovegin in the treatment of the central and the peripheral nervous system
Boriskina, L. M. (2015) · Neuromuscular Diseases · doi:10.17650/2222-8721-2015-5-2-25-31 · Cited by 4
Singh, J. (2018) · Open access Journal of Neurology & Neurosurgery · doi:10.19080/oajnn.2018.09.555759 · Cited by 2
Drat-Gzubicka, J., Pyszora, A., Budzyński, J., Currow, D. C., & Krajnik, M. (2021) · Diagnostics · doi:10.3390/diagnostics11081377 · Cited by 2
“Compared to other patient groups, the NP-RPN rate in this study was similar to the rates reported for diabetic patients (21–60%) [30] and lower than the rate of painful polyneuropathy found in patients with polyneuropathy of various etiologies [31].”
ResultTo Be, or Not To Be … a Biomarker? A Question to the FDA
Alam, U. (2021) · Clinical Therapeutics · doi:10.1016/j.clinthera.2021.08.010 · Cited by 2
Effects of Upregulation of TNFAIP3 on Diabetic Neuropathic Pain in Mice
Liu, Y., Li, J., Yao, H., et al. (2021) · Disease Markers · doi:10.1155/2021/3470950 · Cited by 2
Naeini, M. K., Moghimbeigi, A., Kiani, J., et al. (2016) · Epidemiology and Health · doi:10.4178/epih/e2016011 · Cited by 2
Dziemidok, P., Gorczyca-Siudak, D., & Makara‐Studzińska, M. (2023) · Medical Science Monitor · doi:10.12659/msm.939043 · Cited by 3
PRESENCE OF SUBCLINICAL POLYNEUROPATHY IN PATIENTS WITH ELEVATION OF HbA1c
Çetinkaya, Y., Özdemir, G., Bayır, B. R. H., & Mısırlı, C. H. (2023) · Nöro Psikiyatri Arşivi · doi:10.29399/npa.28413 · Cited by 2
Zaganjor, I., Saelee, R., Miyamoto, Y., Xu, F., & Pavkov, M. E. (2024) · Primary care diabetes · doi:10.1016/j.pcd.2024.12.008 · Cited by 3
Neuropatia diabetica in Italia
Spallone, V. (2012) · Cineca Institutional Research Information System (Tor Vergata University) · Cited by 2
Diabetes and the Nervous System
Vinik, A. I., CASELLINI, C. M., & Neuman, S. (2018) · Endocrinology · doi:10.1007/978-3-319-27316-7_10-1 · Cited by 2
Петрович, Ж. А., Александровна, Ш. И., Васильевна, К. З., & Golberg, O. A. (2020) · Современные проблемы науки и образования · doi:10.17513/spno.29919 · Cited by 2
“Не у всех пациентов с периферической нейропатией или повреждением центральной нервной системы развивается нейропатическая боль [33, 34].”
Mechanisms of Diabetic Neuropathies and Antioxidant Therapy
Alsulaimani, M. A., Magadmi, R. M., & Esmat, A. (2020) · Journal of Pharmaceutical Research International · doi:10.9734/jpri/2020/v32i3530977 · Cited by 2
“DM patients without neuropathy [66] but 60%– 65.”
BackgroundPainful Diabetic Neuropathy as a Cause for Refractory Ear Pain in Type 2 Diabetic Patients
Attia, T. M., & Hamdan, A. M. (2022) · Otology & Neurotology · doi:10.1097/mao.0000000000003526 · Cited by 2
Ala, S., Enayatifard, R., Monajati, M., et al. (2022) · SN Comprehensive Clinical Medicine · doi:10.1007/s42399-021-01108-7 · Cited by 1
Pathophysiology of Neuropathic Pain
Themistocleous, A. C., & Bačkonja, M. (2023) · Contemporary diabetes · doi:10.1007/978-3-031-15613-7_23 · Cited by 1
An examination of the poor correlation between symptoms and signs of dry eye disease
McMonnies, C. W. (2024) · Expert Review of Ophthalmology · doi:10.1080/17469899.2024.2373204 · Cited by 2
“A study of tertiary care hospital type II diabetes mellitus patients in India found a diabetic peripheral neuropathy prevalence of 29.2% [49] and a study of community health care patients in England found 33% of all diabetic patients have painful neuropathy symptoms [50].”
InfluentialRegional and interregional functional and structural brain abnormalities in neuropathic pain
El‐Sayed, R., & Davis, K. D. (2024) · International review of neurobiology · doi:10.1016/bs.irn.2024.10.007 · Cited by 4
Aggarwal, P., Mishra, P. N., Mathur, V. N., et al. (2025) · Cureus · doi:10.7759/cureus.79722 · Cited by 1
“It has been reported that one-third of all community-based diabetic patients have painful neuropathy symptoms; it is also reported that peripheral diabetic neuropathy is more prevalent in patients with type 2 diabetes, women, and people of South Asian origin [16].”
Lin, K., Wang, X., Gu, T., Feng, K., Wang, Z., & Liu, Y. (2025) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s485853 · Cited by 1
“13,17 The impact of pDPN on patients’ quality of life, emotional well-being, and functional status necessitates a deeper understanding of the underlying pathophysiology.”
Khan, S., Bhanot, A., & Bhandari, D. D. (2025) · Scripta Medica · doi:10.5937/scriptamed56-52822 · Cited by 3
Šiaulienė, L., Sereikė, I., Lazutka, J. R., Semigrejevienė, J., & Visockienė, Ž. (2025) · Diabetology · doi:10.3390/diabetology6080074 · Cited by 1
Basu, P., dos Santos, D. F. D. S., Gakii, N. E., Gralinski, M., Griggs, R. B., Brings, S., Fleming, T. H., Susuki, K., & Taylor, B. K. (2025) · PAIN Reports · doi:10.1097/pr9.0000000000001312 · Cited by 1
Chiam, G., Smith, S., Tu, T., Din, A., Normahani, P., & Davies, A. H. (2025) · Diabetic Medicine · doi:10.1111/dme.70134 · Cited by 1
Zhang, H., Qin, Z., & Feng, X. (2025) · Journal of International Medical Research · doi:10.1177/03000605251382382 · Cited by 1
“19 Following the diagnosis of PV in the current case, the patient’s lower limb pain significantly improved with treatment using aspirin and IFN-a , further suggesting that the pain was not solely caused by PDN.”
InfluentialGuo, H., Wang, Y., Lv, H., & Shi, B. (2025) · Pain and Therapy · doi:10.1007/s40122-025-00789-5 · Cited by 1
Elsayegh, D., Tluli, O., Elzayyat, M., Karen, A. A., Albarghouthi, L., Al-Emadi, A., AlMaadid, M., Al-Mohannadi, H., & Djouhri, L. (2025) · Journal of drug targeting · doi:10.1080/1061186x.2025.2587701 · Cited by 1
Early Diagnosis of Diabetic Neuropathy: A Review of Current Diagnostic Tests
Alkhafaji, M., & Otti, V. (2025) · Cureus · doi:10.7759/cureus.97880 · Cited by 6
Toqeer, M., Babar, M. U. Z., Bhatti, A., Israr, S., Masood, E., Malik, F. A., Rizwan, Z., & Mehboob, A. A. (2026) · Cureus · doi:10.7759/cureus.101955 · Cited by 1
Mechanisms and Clinical Application Progress of Exercise in the Treatment of Neuropathic Pain
Li, X., & JinZhu, B. (2026) · Cellular and Molecular Neurobiology · doi:10.1007/s10571-026-01678-x · Cited by 1
“Diabetic peripheral neuropathy (DPN) is among the most common chronic complications of diabetes, with a prevalence ranging from 6 to 51% (Abbott et al. 2011 ; Hicks and Selvin 2019; Tesfaye et al. 1996; Gregg et al. 2007).”
Cerebral alterations associated with painful diabetic peripheral neuropathy
Li, Y., Siyao, Z., Liu, C., Liu, H., & Feng, Z. (2026) · Anesthesiology and Perioperative Science · doi:10.1007/s44254-025-00151-0 · Cited by 1
“The painful phase of DPN-clinically defined as painful diabetic peripheral neuropathy (PDN)—occurs in 25% to 50% of patients diagnosed with DPN [2, 3].”
Xu, X., Huang, S. D., Wang, F., Guo, L., Liao, S., Yang, M., & Wang, Z. (2026) · Frontiers in Neurology · doi:10.3389/fneur.2026.1746503 · Cited by 1
“Additionally, higher levels of neuropathic pain are reported in T2DM patients, women, and people of South Asian ethnicity (86); female sex is a potential risk factor for painful DPN (88).”
Delgado, N., Chaytor, N. S., Beeri, M. S., Hawks, Z., Jung, L., Cleveland, M. J., Bulger, J., Grinspoon, E. A., Janess, K., Zuniga-Kennedy, M., et al. (2026) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2026.113256 · Cited by 1
Awad, G., Boutros, M., Abboud, E., Mjahed, G. A., & Yammine, K. (2026) · Neuromodulation Technology at the Neural Interface · doi:10.1016/j.neurom.2026.03.008 · Cited by 1
Hemmati, D. M. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-10583-8.00037-4 · Cited by 1
Electrochemical aptasensing reveals serum myelin alterations in diabetic neuropathy
Serin, M., Vahabi, A., Birim, D., Armağan, G., Sertöz, N., Kara, P., & Ozturk, A. M. (2026) · Analytical Biochemistry · doi:10.1016/j.ab.2026.116156 · Cited by 2
Effects of peripheral nerve damage on promoting maladaptive plasticity in the spinal cord and brain
Dalrymple, A. N., Senger, J. B., Staples, J. W., Harrison, A. T., Webber, C. A., & Weber, D. J. (2026) · Neuroscience · doi:10.1016/j.neuroscience.2026.05.016 · Cited by 1
Ignacy, P., Gut-Misiaga, M., Gil, A., Kwiendacz, H., Gumprecht, J., Lip, G. Y. H., Alam, U., & Nabrdalik, K. (2026) · Clinical Therapeutics · doi:10.1016/j.clinthera.2026.07.012 · Cited by 1
Heterogeneity in diabetic distal neuropathy and differential approach to its treatment
Хуторная, О. Е., Bregovskiy, V. B., Demina, A. G., et al. (2013) · Diabetes Mellitus · doi:10.14341/2072-0351-3757 · Cited by 1
Vitamin D and painful diabetic neuropathy: missing link or innocent bystander?
Alam, U., & Malik, R. A. (2013) · Diabetes Management · doi:10.2217/dmt.13.28 · Cited by 1
Self-citationLomova-Williams, L., Mallipedhi, A., MacIver, C., Price, D. E., Thomas, R., Ferguson, C., & Stephens, J. W. (2014) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2014.11.016 · Cited by 1
Heydari, M., Homayouni, K., Hashempur, M. H., et al. (2014) · International Journal of Research in Ayurveda and Pharmacy · doi:10.7897/2277-4343.056135 · Cited by 1
Metadata
- Authors
- Abbott, C. A., Malik, R. A., van Ross, E. R. E., Kulkarni, J., & Boulton, A. J. M.
- Affiliations
- University of Manchester (GB)
- Disablement Services Centre, Withington Hospital, Manchester, U.K.
- Withington Community Hospital (GB)
- Corresponding author
- Abbott, Caroline A.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2011-09-15
- Volume
- 34
- Issue
- 10
- Pages
- 2220-2224
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3177727
- OpenAlex
- W2162902338
- Semantic Scholar
- f503e4898de5486de267534e888652f729e9319c
- Cited by
- 868
- References
- 19
- Citations by year
- 2026: 38 · 2025: 67 · 2024: 74 · 2023: 69 · 2022: 70 · 2021: 97 · 2020: 99 · 2019: 64 · 2018: 54 · 2017: 48 · 2016: 47 · 2015: 52 · 2014: 41 · 2013: 35 · 2012: 12
- FWCI
- 19.19
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-nd
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Research Explorer (The University of Manchester) (publishedVersion)
- e-space (Manchester Metropolitan University) (acceptedVersion)
- Research Explorer (The University of Manchester) (submittedVersion)
- Funders
- American Diabetes Association
- National Institute for Health and Care Research
- Topics
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Health Sciences › Medicine › Clinical Neurology › Peripheral Neuropathies and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetic Foot Ulcer Assessment and Management
- Keywords
- diabetic neuropathic pain, prevalence, type 2 diabetes, type 1 diabetes, sex differences, ethnicity, South Asians, neuropathy severity, neuropathic pain, neuropathy screening
- MeSH terms
- Administration, Oral, Adult, Aged, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Diabetic Neuropathies, Female, United Kingdom, Humans, Hypoglycemic Agents, Male, Middle Aged, Sex Factors, Age Distribution
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
